Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Observational Cohort Study to Describe the Use of Vectibix in Combination With Chemotherapy in Routine Clinical Practice for Patients With Wild-type RAS Metastatic Colorectal Cancer

Trial Profile

Prospective Observational Cohort Study to Describe the Use of Vectibix in Combination With Chemotherapy in Routine Clinical Practice for Patients With Wild-type RAS Metastatic Colorectal Cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2019

At a glance

  • Drugs Panitumumab (Primary) ; Antineoplastics
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 28 Jan 2019 Results published in the Advances in Therapy
    • 07 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 26 Feb 2016 Planned End Date changed from 1 Jan 2017 to 1 Nov 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top